Cargando…

Citrate: How to Get Started and What, When, and How to Monitor?

In most of the case, regional citrate anticoagulation is using diluted citrate around 1% depending on the types used in clinical practice. Diluted citrate is much more safer when compared to highly concentrated citrate around 4% or even more. In clinical practice, trisodium citrate is used in high c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Honore, Patrick M., De Bels, David, Preseau, Thierry, Redant, Sebastien, Spapen, Herbert D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sciendo 2018
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6231307/ https://www.ncbi.nlm.nih.gov/pubmed/30425947 http://dx.doi.org/10.2478/jtim-2018-0026

Ejemplares similares

Efficacy of polymyxin B hemoperfusion in and beyond septic shock: is an “endotoxin severity score” needed?
por: Honore, Patrick M., et al.
Publicado: (2018)

Adjuvant vitamin C in cardiac arrest patients undergoing renal replacement therapy: an appeal for a higher high-dose
por: Honore, Patrick M., et al.
Publicado: (2018)

Clinical benefit of high-volume hemofiltration in severe burn injury: is it removing bad humors or actually avoiding hypervolemia?
por: Honore, Patrick M., et al.
Publicado: (2018)

Prone Positioning in Coronavirus Disease 2019 Patients with Acute Respiratory Distress Syndrome: How and When is the Best Way to do it?
por: De Bels, David, et al.
Publicado: (2021)

Dexmedetomidine: the first new kid on the block for preventing cardiac surgery-associated acute kidney injury?
por: Honore, Patrick M., et al.
Publicado: (2018)

Eliminating endotoxin by polymyxin B hemoperfusion and/or continuous renal replacement therapy: should the focus be on timing, dosing, and type of renal epuration?
por: Honore, Patrick M., et al.
Publicado: (2019)

Liquorice Intoxication Can Lead to Cardiac Arrest!
por: Attou, Rachid, et al.
Publicado: (2020)

Optimizing micafungin dosing in critically ill patients: what about extracorporeal therapies?
por: Honore, Patrick M., et al.
Publicado: (2018)

Reliability of biomarkers of sepsis during extracorporeal therapies: the clinician needs to know what is eliminated and what is not
por: Honore, Patrick M., et al.
Publicado: (2020)

Heparin-binding protein in sepsis: player! predictor! positioning?
por: Honore, Patrick M., et al.
Publicado: (2019)

Some metabolic issues should not be neglected when using citrate for continuous renal replacement therapy!
por: Jacobs, Rita, et al.
Publicado: (2015)

Inducible metabolic pathway for citrate metabolism in case of major liver dysfunction: fact or fiction?
por: Honore, Patrick M., et al.
Publicado: (2019)

How levosimendan can improve renal function?
por: Honore, Patrick M., et al.
Publicado: (2019)

Study conclude that routinely monitoring of sputum viral load in severe COVID-19 patients may be beneficial for development of infection control guidelines and prediction of prognosis: We are not sure!
por: Honore, Patrick M., et al.
Publicado: (2022)

In severe liver disease, citrate can be used safely: the question remains—by which mechanism
por: Honore, Patrick M., et al.
Publicado: (2020)

Use of Extracorporeal Membrane Oxygenation in Patients with Refractory Cardiac Arrest due to Severe Persistent Hypothermia: About 2 Case Reports and a Review of the Literature
por: Attou, Rachid, et al.
Publicado: (2021)

Validity of the relationship between mobility group box-1 protein and poor post–cardiac arrest neurological outcome during renal replacement therapy
por: Honore, Patrick M., et al.
Publicado: (2019)

Dosing adjuvant vitamin C in critically ill patients undergoing continuous renal replacement therapy: We are not there yet!
por: Honore, Patrick M., et al.
Publicado: (2019)

Hyperchloremia-associated acute chronic kidney injury: beware of confounders!
por: Honore, Patrick M., et al.
Publicado: (2019)

Vancomycin pharmacokinetics in critically ill obese patients: can the clinician sit back and relax?
por: Honore, Patrick M., et al.
Publicado: (2019)

Vitamin C Dosing During Continuous Renal Replacement Therapy: The Last Word is Not Said!
por: Honore, Patrick M., et al.
Publicado: (2019)

High levels of plasma biomarkers at 24 h were found to be strong predictors of 90-day mortality: beware of some potential confounders!
por: Honore, Patrick M., et al.
Publicado: (2021)

A Study Revealed That a High Percentage of Patients With Severe COVID-19 With Viral RNAaemia Had Significantly Worse Outcomes, and This Is the First Report About the Risk Factors of Viral RNAaemia in Patients With COVID-19: We Are Not Sure!
por: Honore, Patrick M., et al.
Publicado: (2021)

Spontaneous Pneumothorax (SP) in COVID-19 Is Associated With Worse Outcomes Than SP in Non-COVID-19 Patients, Which Suggests That SP in COVID-19 is a Sign of Disease Severity: Is This Finding a Pure Association or Is There Really a Strong Relationship Between the Two?
por: Honore, Patrick M., et al.
Publicado: (2021)

Are SOFA score, PaO(2)/FiO(2) ratio, lymphocytes levels, total bilirubin, lactate dehydrogenase, ferritin, C-reactive protein and interleukin-6 significantly normalized following TPE completion: Is this fact or fiction?
por: Honore, Patrick M., et al.
Publicado: (2021)

Get momentum: how to start when you're stuck
por: Womack, Jason W, et al.
Publicado: (2016)

MR-proADM has a good ability to predict 28-day mortality in critically ill patients with SARS-CoV-2 pneumonia: Beware of some potential confounders!
por: Honore, Patrick M., et al.
Publicado: (2022)

Indirect calorimetry is the gold standard to assess REE in ICU patients: some limitations to consider
por: Honore, Patrick M., et al.
Publicado: (2021)

Study find that COVID ARDS was associated with a low risk for possible or proven PCP: still true after dexamethasone use
por: Honore, Patrick M., et al.
Publicado: (2022)

Success rate of naso-jejunal tube placement influenced by CRRT: possible removal of metoclopramide
por: Honore, Patrick M., et al.
Publicado: (2021)

Higher incidence of arrhythmia in COVID-19 than in other community-acquired pneumonia: possible role of concurrent therapies
por: Honore, Patrick M., et al.
Publicado: (2021)

Differentiating Hyperlactatemia Type a From Type B: How Does the Lactate/pyruvate Ratio Help?
por: Redant, Sebastien, et al.
Publicado: (2019)

Study conclude that TXA in severely injured was associated with lower mortality: beware of potential confounders
por: Honore, Patrick M., et al.
Publicado: (2021)

Comparison between meropenem and ceftolozane/tazobactam: possible influence of CRRT
por: Honore, Patrick M., et al.
Publicado: (2022)

Liver injury without liver failure in COVID-19 patients: how to explain, in some cases, elevated ammonia without hepatic decompensation
por: Honore, Patrick M., et al.
Publicado: (2020)

Fifty Shades of Central Venous Pressure in the Cardiorenal Syndrome
por: Redant, Sebastien, et al.
Publicado: (2020)

Is an EAA > 0.6 in severe COVID-19 patients synonymous with a toxic and pro-inflammatory endotoxin profile, and should we treat it?
por: Honore, Patrick M., et al.
Publicado: (2021)

How to get started in quality improvement
por: Jones, Bryan, et al.
Publicado: (2019)

Optimizing citrate dose for regional anticoagulation in continuous renal replacement therapy: measuring citrate concentrations instead of ionized calcium?
por: Honore, Patrick M., et al.
Publicado: (2015)

Cardiogenic Shock after Nifedipine Administration in a Pregnant Patient: A Case Report and Review of the Literature
por: Botta, Ilaria, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_568p0pdbu4ijib663srj0vu49m